Agilent Application Note: Ulcer Medications Analysis

This Application Note describes the basic principles and conditions of using Agilent ZORBAX StableBond columns to separate ulcer drugs.

Brand: Agilent
Category: Other
Document type: Other
Language: English
Pages: 2
File format: PDF
File size: 224 KB
Published: 03 July, 2012
Updated: 30 September, 2023
MD5 checksum: CBACC43E91A17450E7CC8489AC9AFA1C
PDF: Agilent Application Note: Ulcer Medications Analysis PDF

About this manual

This document is an application note detailing the analysis of ulcer medications, specifically Cimetidine, Famotidine, and Pirenzepine. It explains that these drugs work as histamine H2-receptor antagonists to treat ulcers by inhibiting stomach acid production. The text notes that ulcer medications are the second most frequently prescribed drugs after cardiac drugs.

What's inside

Application
Ulcer Medications
HPLC Conditions
Column Information
Highlights

Specifications

Column	ZORBAX SB-CN (4.6 x 150 mm; 3.5um)
Mobile Phase	90% 25 mM NaH2PO4 Monobasic (pH 3.0) : 10% Acetonitrile
Flow Rate	1 mL/min
Temperature	35°C
Detection	UV (220 nm)

Frequently asked questions

What is the purpose of this application note?

This application was developed for general interest regarding the analysis of ulcer medications.

What is the column temperature setting?

The column temperature is set to 35°C.

What is the flow rate for the mobile phase?

The flow rate is set to 1 mL/min.

Download PDF (224 KB)